These results suggest that TP inhibits TGF-β1/Smad signaling in CFs by decreasing the MyD88-mediated activation of JNK and ERK1/2. The gene discussed is TGFB1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.